318 related articles for article (PubMed ID: 22407319)
1. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response.
Sanada T; Kim M; Mimuro H; Suzuki M; Ogawa M; Oyama A; Ashida H; Kobayashi T; Koyama T; Nagai S; Shibata Y; Gohda J; Inoue J; Mizushima T; Sasakawa C
Nature; 2012 Mar; 483(7391):623-6. PubMed ID: 22407319
[TBL] [Abstract][Full Text] [Related]
2. Complex structure of OspI and Ubc13: the molecular basis of Ubc13 deamidation and convergence of bacterial and host E2 recognition.
Fu P; Zhang X; Jin M; Xu L; Wang C; Xia Z; Zhu Y
PLoS Pathog; 2013; 9(4):e1003322. PubMed ID: 23633953
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the recognition of Ubc13 by the Shigella flexneri effector OspI.
Nishide A; Kim M; Takagi K; Himeno A; Sanada T; Sasakawa C; Mizushima T
J Mol Biol; 2013 Aug; 425(15):2623-31. PubMed ID: 23542009
[TBL] [Abstract][Full Text] [Related]
4. Deamidation disrupts native and transient contacts to weaken the interaction between UBC13 and RING-finger E3 ligases.
Mohanty P; Agrata R; Habibullah BI; G S A; Das R
Elife; 2019 Oct; 8():. PubMed ID: 31638574
[TBL] [Abstract][Full Text] [Related]
5. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.
Sun L; Deng L; Ea CK; Xia ZP; Chen ZJ
Mol Cell; 2004 May; 14(3):289-301. PubMed ID: 15125833
[TBL] [Abstract][Full Text] [Related]
6. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes.
Kim DW; Lenzen G; Page AL; Legrain P; Sansonetti PJ; Parsot C
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):14046-51. PubMed ID: 16162672
[TBL] [Abstract][Full Text] [Related]
7. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4.
Dong W; Liu Y; Peng J; Chen L; Zou T; Xiao H; Liu Z; Li W; Bu Y; Qi Y
J Biol Chem; 2006 Sep; 281(36):26029-40. PubMed ID: 16831874
[TBL] [Abstract][Full Text] [Related]
8. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.
Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M
J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209
[TBL] [Abstract][Full Text] [Related]
9. Shigella flexneri T3SS effector IpaH4.5 modulates the host inflammatory response via interaction with NF-κB p65 protein.
Wang F; Jiang Z; Li Y; He X; Zhao J; Yang X; Zhu L; Yin Z; Li X; Wang X; Liu W; Shang W; Yang Z; Wang S; Zhen Q; Zhang Z; Yu Y; Zhong H; Ye Q; Huang L; Yuan J
Cell Microbiol; 2013 Mar; 15(3):474-85. PubMed ID: 23083102
[TBL] [Abstract][Full Text] [Related]
10. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.
McCully RR; Pomerantz JL
Mol Cell Biol; 2008 Sep; 28(18):5668-86. PubMed ID: 18625728
[TBL] [Abstract][Full Text] [Related]
11. Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation.
Oeckinghaus A; Wegener E; Welteke V; Ferch U; Arslan SC; Ruland J; Scheidereit C; Krappmann D
EMBO J; 2007 Nov; 26(22):4634-45. PubMed ID: 17948050
[TBL] [Abstract][Full Text] [Related]
12. Multiple protein domains mediate interaction between Bcl10 and MALT1.
Langel FD; Jain NA; Rossman JS; Kingeter LM; Kashyap AK; Schaefer BC
J Biol Chem; 2008 Nov; 283(47):32419-31. PubMed ID: 18806265
[TBL] [Abstract][Full Text] [Related]
13. STAT3 restrains RANK- and TLR4-mediated signalling by suppressing expression of the E2 ubiquitin-conjugating enzyme Ubc13.
Zhang H; Hu H; Greeley N; Jin J; Matthews AJ; Ohashi E; Caetano MS; Li HS; Wu X; Mandal PK; McMurray JS; Moghaddam SJ; Sun SC; Watowich SS
Nat Commun; 2014 Dec; 5():5798. PubMed ID: 25503582
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C-δ negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosome.
Liu Y; Song R; Gao Y; Li Y; Wang S; Liu HY; Wang Y; Hu YH; Shu HB
J Biol Chem; 2012 Jun; 287(24):20081-7. PubMed ID: 22528498
[TBL] [Abstract][Full Text] [Related]
15. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.
Newton HJ; Pearson JS; Badea L; Kelly M; Lucas M; Holloway G; Wagstaff KM; Dunstone MA; Sloan J; Whisstock JC; Kaper JB; Robins-Browne RM; Jans DA; Frankel G; Phillips AD; Coulson BS; Hartland EL
PLoS Pathog; 2010 May; 6(5):e1000898. PubMed ID: 20485572
[TBL] [Abstract][Full Text] [Related]
16. The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation.
Palkowitsch L; Marienfeld U; Brunner C; Eitelhuber A; Krappmann D; Marienfeld RB
J Biol Chem; 2011 Mar; 286(9):7522-34. PubMed ID: 21199863
[TBL] [Abstract][Full Text] [Related]
17. A nucleation barrier spring-loads the CBM signalosome for binary activation.
Rodriguez Gama A; Miller T; Lange JJ; Unruh JR; Halfmann R
Elife; 2022 Jun; 11():. PubMed ID: 35727133
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses.
Fukushima T; Matsuzawa S; Kress CL; Bruey JM; Krajewska M; Lefebvre S; Zapata JM; Ronai Z; Reed JC
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6371-6. PubMed ID: 17404240
[TBL] [Abstract][Full Text] [Related]
19. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.
Zurawski DV; Mumy KL; Badea L; Prentice JA; Hartland EL; McCormick BA; Maurelli AT
Infect Immun; 2008 Jan; 76(1):369-79. PubMed ID: 17984206
[TBL] [Abstract][Full Text] [Related]
20. Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity.
Brenke JK; Popowicz GM; Schorpp K; Rothenaigner I; Roesner M; Meininger I; Kalinski C; Ringelstetter L; R'kyek O; Jürjens G; Vincendeau M; Plettenburg O; Sattler M; Krappmann D; Hadian K
J Biol Chem; 2018 Aug; 293(34):13191-13203. PubMed ID: 29950522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
